SCHEMBL6046074

SCHEMBL6046074

Cc1ccc(S(=O)(=O)Nc2ccc(CC(CC(=O)NO)C(=O)NC3c4ccccc4CC3O)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 17/20 0.68
MMP2 P08253 15/20 0.68
MMP1 P03956 11/20 0.68
MMP8 P22894 7/20 0.68
VIPR2 P41587 1/20 0.64
ADAMTS4 O75173 1/20 0.60
ADAMTS5 Q9UNA0 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6046079 1.00 MMP9 (0.68) MMP9MMP2MMP1MMP8VIPR2
SCHEMBL6046070 0.88 MMP9 (0.81) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046063 0.88 MMP9 (0.81) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046057 0.81 MMP9 (1.00) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046048 0.81 MMP9 (1.00) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046094 0.81 MMP9 (1.00) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046088 0.81 MMP9 (1.00) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046178 0.81 MMP9 (0.83) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046129 0.81 MMP9 (0.83) MMP9MMP2MMP1MMP8ADAMTS4
SCHEMBL6046121 0.81 MMP9 (0.83) MMP9MMP2MMP1MMP8ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576664-B1 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-06-10 US claimed
US-20060281699-A1 Methods, compositions and compound assays for inhibiting amyloid-beta protein production MERCHIERS PASCAL G 2006-12-14 US disclosed
US-6576664-B1 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-06-10 US disclosed